Dee Wynne

Clinical And Immunologic Responses To Human Immunodeficiency Virus (HIV) Type LSF2 gp120 Subunit Vaccine Combined With MF59 Adjuvant With Or Without Muramyl Tripeptide Dipalmitoyl Phosphatidylethanolamine In Non-HIV-Infected Human Volunteers

James O. Kahn, Faruk Sinangil, John E. Baenziger et al. · The Journal of Infectious Diseases · 1994 · 109 citations

Life Sciences, Immunology, Infectious Diseases +16

Phase 1 Study of Lumiliximab with Detailed Pharmacokinetic and Pharmacodynamic Measurements in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

John C. Byrd, Susan O’Brien, Ian W. Flinn et al. · Clinical Cancer Research · 2007 · 102 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

John C. Byrd, Thomas J. Kipps, Ian W. Flinn et al. · Blood · 2009 · 100 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Phase I Trial of Interferon gamma Retroviral Vector Administered Intratumorally with Multiple Courses in Patients with Metastatic Melanoma

John Nemunaitis, Timothy Fong, Francis Burrows et al. · Human Gene Therapy · 1999 · 42 citations

Medicine, Immunology, Oncology +14

Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma

John Nemunaitis, Timothy Fong, Joan M. Robbins et al. · Cancer Gene Therapy · 1999 · 40 citations

Medicine, Immunology, Oncology +14